Telix Pharmaceuticals Lim... (TLPPF)

PNK: TLPPF · Real-Time Price · USD

17.00

-0.00 (-0.01%)

At close: Apr 30, 2025, 1:33 PM

Telix Pharmaceuticals Balance Sheet Statement

Financials in AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	710.35M	123.24M	116.33M	22.04M	77.94M	44.6M	25.77M	48.76M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	6.09M	12.26M	-5.52M	n/a	-4.22M	n/a	1.14M	n/a
Other Long-Term Assets	74.58M	586K	327K	-3.88M	183K	-4.14M	1.17M	35.29K
Receivables	158.99M	64.78M	39.35M	20.84M	14.19M	13.01M	8.97M	488.83K
Inventory	38.14M	17.31M	8.48M	3.45M	633K	542K	642.52K	297.22K
Other Current Assets	n/a	7.1M	6.57M	n/a	n/a	n/a	n/a	n/a
Total Current Assets	918.56M	224.85M	173.23M	47.54M	93.63M	58.68M	35.86M	49.55M
Property-Plant & Equipment	54.32M	30.49M	18.84M	6.33M	4.82M	1.9M	226.17K	5.39K
Goodwill & Intangibles	416.13M	109.66M	64.5M	59.83M	63.41M	46.17M	39.45M	1.51M
Total Long-Term Assets	597.87M	173.45M	87.36M	62.27M	70.81M	43.93M	40.85M	1.55M
Total Assets	1.52B	398.3M	260.59M	109.81M	164.44M	102.61M	76.71M	51.09M
Account Payables	68.7M	32.84M	16.81M	11.88M	5.81M	6.96M	3.25M	275.84K
Deferred Revenue	11.25M	n/a	4.94M	6.14M	3.23M	n/a	3.64M	n/a
Short-Term Debt	18.99M	964K	n/a	19K	264K	469K	1.13M	345.43K
Other Current Liabilities	109.67M	74.14M	47.33M	14.12M	7.65M	2.72M	3.38M	847.17K
Total Current Liabilities	330.91M	157.41M	85.56M	37.98M	19.96M	10.63M	8.24M	1.47M
Long-Term Debt	551.82M	8.21M	3.31M	n/a	95K	292K	596.29K	n/a
Other Long-Term Liabilities	44.67M	76.1M	55.31M	43.23M	28.91M	16.44M	10.59M	n/a
Total Long-Term Liabilities	617.31M	91.98M	92.88M	68.19M	64.49M	21.25M	15.56M	332.49K
Total Liabilities	948.22M	249.39M	178.44M	106.17M	84.44M	31.88M	23.8M	1.8M
Total Debt	581.45M	17.45M	10.45M	2.54M	2.21M	2.13M	1.73M	345.43K
Common Stock	n/a	446.27M	370.97M	170.84M	167.06M	115.94M	72.05M	55.56M
Retained Earnings	-212.96M	-263.67M	-272.81M	-173.47M	-92.96M	-48.07M	-20.21M	-6.38M
Comprehensive Income	184.4M	-33.69M	-18.15M	4.79M	4.92M	2.21M	1.06M	109K
Shareholders Equity	568.21M	148.91M	80.01M	2.16M	79.02M	70.08M	52.9M	49.29M
Total Investments	6.09M	12.26M	-5.52M	n/a	-4.22M	n/a	1.14M	n/a